Price $28.10 |
Market Cap
2.18B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.74
|
P/S
1.27
|
Dividend %
-
|
|
P/CF
90.2
|
P/FCF
47.0
|
Op. Cash Flow
178.1K
|
FCF
0.6
|
|
Op. Margin
3.70%
|
Net Margin
-0.90%
|
ROE
-4.20%
|
ROI
3.10%
|
|
ROA
-0.60%
|
EPS Growth
-166.10%
|
Current Ratio
0.8
|
Debt/Equity
252.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Soligenix Inc (SNGX) | $0.53 | - | - | 5.7M | Strong Buy |
| Baxter International Inc (BAX) | $38.96 | - | 2.50% | 23.05B | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $1.60 | - | - | 6M | Strong Buy |
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
| Avinger Inc (AVGR) | $10.45 | - | - | 7.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
